Mario Morotti - Publications

Affiliations: 
University of Oxford, Oxford, United Kingdom 

83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Tantari M, Bogliolo S, Morotti M, Balaya V, Bouttitie F, Buenerd A, Magaud L, Lecuru F, Guani B, Mathevet P. Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study. Cancers. 14. PMID 35008376 DOI: 10.3390/cancers14010212  0.614
2021 Valenti G, Vitagliano A, Morotti M, Giorda G, Sopracordevole F, Sapia F, Lo Presti V, Chiofalo B, Forte S, Lo Presti L, Tozzi R. Risks factors for anastomotic leakage in advanced ovarian cancer: A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 269: 3-15. PMID 34942555 DOI: 10.1016/j.ejogrb.2021.12.007  0.614
2021 Cocozza G, Garofalo S, Morotti M, Chece G, Grimaldi A, Lecce M, Scavizzi F, Menghini R, Casagrande V, Federici M, Raspa M, Wulff H, Limatola C. The feeding behaviour of ALS mouse models is modulated by the Ca -activated KCa3.1 channels. British Journal of Pharmacology. PMID 34411281 DOI: 10.1111/bph.15665  0.545
2021 Addley S, Morotti M, Pinelli C, Soleymani Majd H. Transdiaphragmatic resection of enlarged cardiophrenic lymph node during interval debulking surgery for advanced ovarian cancer. Gynecologic Oncology Reports. 37: 100807. PMID 34381861 DOI: 10.1016/j.gore.2021.100807  0.579
2021 Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, Fahr N, Desbuisson M, Grimm A, Zhang H, Chong C, Dagher J, Chee S, Tsianou T, Dorier J, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Reports. 36: 109412. PMID 34289354 DOI: 10.1016/j.celrep.2021.109412  0.611
2021 Sarivalasis A, Morotti M, Mulvey A, Imbimbo M, Coukos G. Cell therapies in ovarian cancer. Therapeutic Advances in Medical Oncology. 13: 17588359211008399. PMID 33995591 DOI: 10.1177/17588359211008399  0.628
2021 Artibani M, Masuda K, Hu Z, Rauher PC, Mallett G, Wietek N, Morotti M, Chong K, KaramiNejadRanjbar M, Zois CE, Dhar S, El-Sahhar S, Campo L, Blagden SP, Damato S, et al. Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells. Jci Insight. PMID 33945502 DOI: 10.1172/jci.insight.147929  0.68
2021 Morotti M, Albukhari A, Alsaadi A, Artibani M, Brenton JD, Curbishley SM, Dong T, Dustin ML, Hu Z, McGranahan N, Miller ML, Santana-Gonzalez L, Seymour LW, Shi T, Van Loo P, et al. Promises and challenges of adoptive T-cell therapies for solid tumours. British Journal of Cancer. PMID 33782566 DOI: 10.1038/s41416-021-01353-6  0.619
2021 Santana Gonzalez L, Rota IA, Artibani M, Morotti M, Hu Z, Wietek N, Alsaadi A, Albukhari A, Sauka-Spengler T, Ahmed AA. Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct. Frontiers in Cell and Developmental Biology. 9: 605301. PMID 33763415 DOI: 10.3389/fcell.2021.605301  0.57
2021 Morotti M, Soleymani Majd H, Casarin J, Alazzam M, Damato S. Histomolecular features of high-grade endometrial cancers. Minerva Medica. 112: 20-30. PMID 33104303 DOI: 10.23736/S0026-4806.20.07082-2  0.643
2021 Pinelli C, Morotti M, Casarin J, Tozzi R, Ghezzi F, Mavroeidis VK, Alazzam M, Soleymani Majd H. Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter? Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research. 34: 1023-1030. PMID 32148117 DOI: 10.1080/08941939.2020.1733146  0.604
2021 Pinelli C, Morotti M, Casarin J, Tozzi R, Alazzam M, Mavroeidis VK, Soleymani Majd H. The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian Cancer. Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research. 34: 756-762. PMID 31809609 DOI: 10.1080/08941939.2019.1690077  0.617
2021 Zannoli S, Sambri A, Morotti M, Tassinari M, Torri A, Bianchi G, De Paolis M, Donati DM, Sambri V. Unyvero ITI system for the clinical resolution of discrepancies in periprosthetic joint infection diagnosis. Musculoskeletal Surgery. 105: 39-42. PMID 31595427 DOI: 10.1007/s12306-019-00626-x  0.545
2020 Demetriou P, Abu-Shah E, Valvo S, McCuaig S, Mayya V, Kvalvaag A, Starkey T, Korobchevskaya K, Lee LYW, Friedrich M, Mann E, Kutuzov MA, Morotti M, Wietek N, Rada H, et al. Author Correction: A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals. Nature Immunology. PMID 33122852 DOI: 10.1038/s41590-020-00825-w  0.533
2020 Morotti M, Zois CE, El-Ansari R, Craze ML, Rakha EA, Fan SJ, Valli A, Haider S, Goberdhan DCI, Green AR, Harris AL. Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. British Journal of Cancer. PMID 33028955 DOI: 10.1038/s41416-020-01113-y  0.785
2020 Demetriou P, Abu-Shah E, Valvo S, McCuaig S, Mayya V, Kvalvaag A, Starkey T, Korobchevskaya K, Lee LYW, Friedrich M, Mann E, Kutuzov MA, Morotti M, Wietek N, Rada H, et al. A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals. Nature Immunology. PMID 32929275 DOI: 10.1038/S41590-020-0770-X  0.54
2020 Blayney J, Foster EM, Jagielowicz M, Kreuzer M, Morotti M, Reglinski K, Xiao JH, Hublitz P. Unexpectedly High Levels of Inverted Re-Insertions Using Paired sgRNAs for Genomic Deletions. Methods and Protocols. 3. PMID 32751356 DOI: 10.3390/mps3030053  0.557
2020 Hu Z, Artibani M, Alsaadi A, Wietek N, Morotti M, Shi T, Zhong Z, Santana Gonzalez L, El-Sahhar S, KaramiNejadRanjbar M, Mallett G, Feng Y, Masuda K, Zheng Y, Chong K, et al. The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells. Cancer Cell. 37: 226-242.e7. PMID 32049047 DOI: 10.1016/J.Ccell.2020.01.003  0.631
2020 Congestrì F, Morotti M, Vicari R, Pedna MF, Sparacino M, Torri A, Bertini S, Fantini M, Sambri V. Comparative evaluation of the novel IMMUNOCATCH Streptococcus pneumoniae (EIKEN CHEMICAL CO., LTD) test with the Uni-Gold Streptococcus pneumoniae assay and the BinaxNOW Streptococcus pneumoniae antigen card for the detection of pneumococcal capsular antigen in urine samples. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 39: 749-751. PMID 31858355 DOI: 10.1007/s10096-019-03778-7  0.546
2019 Del Bianco F, Morotti M, Zannoli S, Dirani G, Fantini M, Pedna MF, Farabegoli P, Sambri V. Comparison of Four Commercial Screening Assays for the Detection of bla, bla, bla, bla and bla in Rectal Secretion Collected by Swabs. Microorganisms. 7. PMID 31888187 DOI: 10.3390/microorganisms7120704  0.564
2019 Tozzi R, Traill Z, Campanile RG, Kilic Y, Baysal A, Giannice R, Morotti M, Soleymani Majd H, Valenti G. Diagnostic flow-chart to identify bowel involvement in patients with stage IIIC-IV ovarian cancer: Can laparoscopy improve the accuracy of CT scan? Gynecologic Oncology. PMID 31481247 DOI: 10.1016/j.ygyno.2019.08.025  0.62
2019 Casarin J, Laganà AS, Uccella S, Cromi A, Pinelli C, Gisone B, Borghi C, Cominotti S, Garzon S, Morotti M, Tozzi R, Ghezzi F. Surgical treatment of large adnexal masses: a retrospective analysis of 330 consecutive cases. Minimally Invasive Therapy & Allied Technologies : Mitat : Official Journal of the Society For Minimally Invasive Therapy. 1-9. PMID 31375049 DOI: 10.1080/13645706.2019.1649700  0.563
2019 Tozzi R, Casarin J, Baysal A, Pinelli C, Matak L, Ghanbarzadeh N, Alazzam M, Garruto-Campanile R, Majd HS, Kilic Y, Morotti M. Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 240: 215-219. PMID 31326636 DOI: 10.1016/j.ejogrb.2019.07.011  0.625
2019 Tozzi R, Casarin J, Baysal A, Valenti G, Kilic Y, Majd HS, Morotti M. Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC?IV ovarian cancer. Journal of Gynecologic Oncology. PMID 31179650 DOI: 10.3802/jgo.2019.30.e101  0.602
2019 Morotti M, Bridges E, Valli A, Choudhry H, Sheldon H, Wigfield S, Gray N, Zois CE, Grimm F, Jones D, Teoh EJ, Cheng WC, Lord S, Anastasiou D, Haider S, et al. Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 31152137 DOI: 10.1073/Pnas.1818521116  0.75
2019 Congestrì F, Morotti M, Vicari R, Pedna MF, Sparacino M, Torri A, Bertini S, Sambri V. Comparison of the Novel Immunocatch Legionella Test with Sofia Legionella FIA Assay and with BinaxNOW Legionella Card Assay for Detection of Legionella pneumophila (Serogroup 1) Antigen in Urine Samples. Journal of Clinical Microbiology. 57. PMID 31092595 DOI: 10.1128/JCM.00305-19  0.556
2019 Valli A, Morotti M, Zois CE, Albers PK, Soga T, Feldinger K, Fischer R, Frejno M, McIntyre A, Bridges E, Haider S, Buffa FM, Baban D, Rodriguez M, Yanes O, et al. Adaptation to HIF1α deletion in hypoxic cancer cells by upregulation of GLUT14 and creatine metabolism. Molecular Cancer Research : McR. PMID 30885992 DOI: 10.1158/1541-7786.MCR-18-0315  0.746
2018 Tozzi R, Casarin J, Baysal A, Valenti G, Kilic Y, Majd HS, Morotti M. Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer. Journal of Gynecologic Oncology. PMID 30740956 DOI: 10.3802/jgo.2019.30.e25  0.61
2018 Motohara T, Masuda K, Morotti M, Zheng Y, El-Sahhar S, Chong KY, Wietek N, Alsaadi A, Karaminejadranjbar M, Hu Z, Artibani M, Gonzalez LS, Katabuchi H, Saya H, Ahmed AA. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene. PMID 30568223 DOI: 10.1038/s41388-018-0637-x  0.655
2018 Ciesielczuk H, Wilks M, Castelain S, Choquet M, Morotti M, Pluquet E, Sambri V, Tassinari M, Zannoli S, Cavalié L, Dupont H, Guet-Revillet H. Multicenter performance evaluation of the Unyvero IAI cartridge for detection of intra-abdominal infections. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 37: 2107-2115. PMID 30094522 DOI: 10.1007/s10096-018-3345-0  0.57
2018 Tozzi R, Casarin J, Belcher E, Campanile RG, Ismail L, Majd HS, Morotti M, Desgro M. Concomitant Laparoscopic and Thoracoscopic Resection of Recurrent High Grade Ovarian Cancer. Journal of Minimally Invasive Gynecology. PMID 29501813 DOI: 10.1016/j.jmig.2018.02.014  0.632
2018 Del Bianco F, Morotti M, Pedna MF, Farabegoli P, Sambri V. Microbiological surveillance of plasmid mediated colistin resistance in human Enterobacteriaceae isolates in Romagna (Northern Italy): August 2016-July 2017. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 69: 96-98. PMID 29447913 DOI: 10.1016/j.ijid.2018.02.006  0.539
2018 Tozzi R, Casarin J, Garruto-Campanile R, Majd HS, Morotti M. Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer. Gynecologic Oncology. 148: 74-78. PMID 29169615 DOI: 10.1016/j.ygyno.2017.11.017  0.626
2018 Ferrero S, Morotti M, Venturini PL, Penuela L, Vellone VG, Barra F. Accuracy of intra-operative frozen section in the diagnosis of borderline ovarian tumors and clinical impact of underdiagnosis Oncology Research and Reviews. 1. DOI: 10.15761/ORR.1000107  0.57
2018 Artibani M, Mallett G, Sunanda D, KaramiNejadRanjbar M, Morotti M, ElSahhar S, Sauka-Spengler T, Ahmed AA. The Oxford Ovarian Cancer Predict Chemotherapy Response (OXO-PCR) study: Understanding the genomic drivers of primary chemotherapy-resistant microscopic residual disease Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-5373  0.615
2018 Garruto Campanile R, Soleymani Majd H, Casarin J, Morotti M, Tozzi R. A prospective study on the diagnostic pathway of patients with stage IIIC-IV ovarian cancer: Can laparoscopy improve CT-scan? Gynecologic Oncology. 149: 237. DOI: 10.1016/J.YGYNO.2018.04.534  0.617
2018 Tozzi R, Soleymani majd H, Garruto Campanile R, Desgro M, Morotti M, Casarin J. Survival outcomes of primary versus interval visceral-peritoneal debulking (VPD) surgery in patients with stage IIIC-IV ovarian cancer and complete resection: A cohort study Gynecologic Oncology. 149: 112-113. DOI: 10.1016/J.YGYNO.2018.04.261  0.62
2017 Morotti M, Dass PH, Harris AL, Lord S. Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients. European Journal of Drug Metabolism and Pharmacokinetics. PMID 29019020 DOI: 10.1007/s13318-017-0442-x  0.763
2017 Stanzani M, Vianelli N, Cavo M, Maritati A, Morotti M, Lewis RE. Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies: A Retrospective Cohort Analysis. Antimicrobial Agents and Chemotherapy. PMID 28607011 DOI: 10.1128/AAC.02651-16  0.556
2017 Morotti M, Venturini PL, Biscaldi E, Racca A, Calanni L, Vellone VG, Stabilini C, Ferrero S. Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 213: 4-10. PMID 28384540 DOI: 10.1016/j.ejogrb.2017.03.033  0.545
2016 Conti F, Brillanti S, Buonfiglioli F, Vukotic R, Morelli MC, Lalanne C, Massari M, Foschi FG, Bernabucci V, Serio I, Prati GM, Negri E, Badia L, Caraceni P, Muratori P, ... ... Morotti M, et al. Safety and efficacy of direct acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older. Journal of Viral Hepatitis. PMID 27976461 DOI: 10.1111/jvh.12663  0.561
2016 Morotti M, Vincent K, Becker CM. Mechanisms of pain in endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. PMID 27522645 DOI: 10.1016/j.ejogrb.2016.07.497  0.558
2016 da Motta LL, Ledaki I, Purshouse K, Haider S, De Bastiani MA, Baban D, Morotti M, Steers G, Wigfield S, Bridges E, Li JL, Knapp S, Ebner D, Klamt F, Harris AL, et al. The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer. Oncogene. PMID 27292261 DOI: 10.1038/onc.2016.184  0.766
2016 Boccardo F, Valenzano M, Costantini S, Casabona F, Morotti M, Sala P, De Cian F, Molinari L, Spinaci S, Dessalvi S, Campisi CC, Villa G, Campisi C. LYMPHA Technique to Prevent Secondary Lower Limb Lymphedema. Annals of Surgical Oncology. 23: 3558-3563. PMID 27221358 DOI: 10.1245/s10434-016-5282-4  0.548
2016 Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Schödel J, Green C, Camps C, Buffa F, Ratcliffe P, Ragoussis I, Mole D, Harris A. Abstract A29: Hypoxia regulated long noncoding RNAs and antisense transcripts in breast cancer: Novel insights of noncoding transcriptional regulation in hypoxic microenvironment Cancer Research. 76. DOI: 10.1158/1538-7445.Nonrna15-A29  0.778
2015 Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, Ratcliffe P, Ragoussis J, Harris AL, Mole DR. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene. 34: 4546. PMID 26289678 DOI: 10.1038/onc.2014.431  0.757
2014 Morotti M, Sozzi F, Remorgida V, Venturini PL, Ferrero S. Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 183: 188-92. PMID 25461377 DOI: 10.1016/j.ejogrb.2014.10.036  0.567
2014 Morotti M, Remorgida V, Venturini PL, Ferrero S. Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 183: 178-82. PMID 25461375 DOI: 10.1016/j.ejogrb.2014.10.029  0.555
2014 Choudhry H, Albukhari A, Morotti M, Hider S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, Ratcliffe P, Ragoussis J, Harris AL, Mole DR. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene. PMID 25417700 DOI: 10.1038/Onc.2014.378  0.754
2014 Morotti M, Remorgida V, Venturini PL, Ferrero S. Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 179: 63-8. PMID 24965982 DOI: 10.1016/j.ejogrb.2014.05.016  0.577
2014 Brawn J, Morotti M, Zondervan KT, Becker CM, Vincent K. Central changes associated with chronic pelvic pain and endometriosis. Human Reproduction Update. 20: 737-47. PMID 24920437 DOI: 10.1093/humupd/dmu025  0.548
2014 Sala P, Morotti M, Menada MV, Cannavino E, Maffeo I, Abete L, Fulcheri E, Menoni S, Venturini P, Papadia A. Intraoperative frozen section risk assessment accurately tailors the surgical staging in patients affected by early-stage endometrial cancer: the application of 2 different risk algorithms. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 24: 1021-6. PMID 24905611 DOI: 10.1097/IGC.0000000000000145  0.6
2014 Morotti M, Vincent K, Brawn J, Zondervan KT, Becker CM. Peripheral changes in endometriosis-associated pain. Human Reproduction Update. 20: 717-36. PMID 24859987 DOI: 10.1093/humupd/dmu021  0.549
2014 Morotti M, Calanni L, Gianola G, Anserini P, Venturini PL, Ferrero S. Changes in sexual function after medical or surgical termination of pregnancy. The Journal of Sexual Medicine. 11: 1495-504. PMID 24636172 DOI: 10.1111/jsm.12506  0.543
2013 Morotti M, Becker CM, Menada MV, Ferrero S. Targeting tyrosine-kinases in ovarian cancer. Expert Opinion On Investigational Drugs. 22: 1265-79. PMID 23815710 DOI: 10.1517/13543784.2013.816282  0.632
2013 Morotti M, Menada MV, Boccardo F, Ferrero S, Casabona F, Villa G, Campisi C, Papadia A. Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 769-74. PMID 23485932 DOI: 10.1097/IGC.0b013e318287a8e8  0.632
2013 Papadia A, Morotti M. Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature. Archives of Gynecology and Obstetrics. 287: 733-41. PMID 23341061 DOI: 10.1007/s00404-013-2715-1  0.627
2013 Morotti M, Ferrero S. Antiangiogenic drugs in the treatment of endometriosis. Reproductive Sciences (Thousand Oaks, Calif.). 20: NP1-2. PMID 23275467 DOI: 10.1177/1933719112468955  0.544
2013 Morotti M, Camerini G, Biscaldi E, Remorgida V, Ferrero S. Pre-Operative Evaluation of an Appendiceal Mucocele in a Woman with Endometriosis Journal of Endometriosis and Pelvic Pain Disorders. 5: 120-122. DOI: 10.5301/je.5000160  0.553
2013 Leone Roberti Maggiore U, Bizzarri N, Morotti M, Remorgida V, Venturini P, Ferrero S. Self-reported sleep quality in women with endometriosis Fertility and Sterility. 100: S366-S367. DOI: 10.1016/J.FERTNSTERT.2013.07.780  0.537
2013 Leone Roberti Maggiore U, Cirafici P, Morotti M, Ferrero S. Self-reported sleep quality in patients undergoing voluntary termination of pregnancy Fertility and Sterility. 100: S416. DOI: 10.1016/J.FERTNSTERT.2013.07.642  0.544
2012 Morotti M, Remorgida V, Buccelli E, Venturini PL, Ferrero S. Comparing treatments for endometriosis-related pain symptoms in patients with migraine without aura. Journal of Comparative Effectiveness Research. 1: 347-57. PMID 24237468 DOI: 10.2217/cer.12.38  0.578
2012 Morotti M, Remorgida V, Venturini PL, Ferrero S. Endometriosis in menopause: a single institution experience. Archives of Gynecology and Obstetrics. 286: 1571-5. PMID 22825693 DOI: 10.1007/s00404-012-2473-5  0.555
2012 Morotti M, Valenzano Menada M, Venturini PL, Ferrero S. Bevacizumab in endometrial cancer treatment. Expert Opinion On Biological Therapy. 12: 649-58. PMID 22428875 DOI: 10.1517/14712598.2012.672558  0.63
2012 Morotti M, Menada MV, Moioli M, Sala P, Maffeo I, Abete L, Fulcheri E, Menoni S, Venturini P, Papadia A. Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. Gynecologic Oncology. 125: 536-40. PMID 22361087 DOI: 10.1016/j.ygyno.2012.02.011  0.624
2012 Morotti M, Valenzano Menada M, Venturini PL, Mammoliti S, Ferrero S. Pemetrexed disodium in ovarian cancer treatment. Expert Opinion On Investigational Drugs. 21: 437-49. PMID 22324304 DOI: 10.1517/13543784.2012.661714  0.635
2012 Morotti M, Menada MV, Gillott DJ, Venturini PL, Ferrero S. The preoperative diagnosis of borderline ovarian tumors: a review of current literature. Archives of Gynecology and Obstetrics. 285: 1103-12. PMID 22210294 DOI: 10.1007/s00404-011-2194-1  0.58
2012 Morotti M, Podestà S, Musizzano Y, Venturini PL, Bentivoglio G, Fulcheri E, Ferrero S. Defective placental adhesion in voluntary termination of second-trimester pregnancy and risk of recurrence in subsequent pregnancies. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 25: 339-42. PMID 21609201 DOI: 10.3109/14767058.2011.576722  0.547
2011 Morotti M, Valenzano Menada M, Venturini PL, Ferrero S. Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment. Expert Opinion On Drug Metabolism & Toxicology. 7: 707-20. PMID 21434836 DOI: 10.1517/17425255.2011.570330  0.631
2011 Ferrero S, Biscaldi E, Morotti M, Venturini PL, Remorgida V, Rollandi GA, Valenzano Menada M. Multidetector computerized tomography enteroclysis vs. rectal water contrast transvaginal ultrasonography in determining the presence and extent of bowel endometriosis. Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 37: 603-13. PMID 21351180 DOI: 10.1002/uog.8971  0.545
2011 Kasapoglu I, Ata B, Ozerkan K, Uncu Y, Celik N, Uncu G, Ferrero S, Morotti M, Leone Roberti Maggiore U, Nicoletti AJ, Venturini PL, Remorgida V, Torok P, Jakab A, Major T, et al. SELECTED ORAL COMMUNICATION SESSION SESSION 06: ENDOMETRIOSIS AND SURGERY Monday 4 July 2011 10:00 - 11:30 Human Reproduction. 26: i11-i14. DOI: 10.1093/humrep/26.s1.6  0.544
2010 Morotti M, Ferrero S, Bogliolo S, Venturini PL, Remorgida V, Valenzano Menada M. Transvaginal ultrasonography with water-contrast in the rectum in the diagnosis of bowel endometriosis. Minerva Ginecologica. 62: 179-85. PMID 20595942  0.555
2010 Bogliolo S, Morotti M, Valenzano Menada M, Fulcheri E, Musizzano Y, Casabona F. Breast cancer with synchronous massive metastasis in the uterine cervix: a case report and review of the literature. Archives of Gynecology and Obstetrics. 281: 769-73. PMID 19876639 DOI: 10.1007/s00404-009-1264-0  0.625
2010 Ferrero S, Morotti M, Menada MV, Venturini PL, Biscaldi E, Camerini G, Remorgida V. Diagnosis of Bowel Endometriosis: A Review Journal of Endometriosis. 2: 71-78. DOI: 10.1177/228402651000200204  0.566
2010 Jiang Y, Zhao J, Hua M, Zhen X, Yan G, Hu Y, Sun H, Selvaggi L, Zannoni GF, Tagliaferri V, De Cicco S, Vellone VG, Romualdi D, Lanzone A, Guido M, ... ... Morotti M, et al. Posters * Endometriosis, Endometrium and Implantation Human Reproduction. 25: i210-i235. DOI: 10.1093/humrep/de.25.s1.242  0.522
1994 Hrelia P, Morotti M, Vigagni F, Maffei F, Paolini M, Mesirca R, Cantelli-Forti G. The modulating activity of interferon on benzo(a)pyrene bioactivation and clastogenesis in mice. Pharmacology & Toxicology. 74: 249-54. PMID 8090695  0.565
1994 Hrelia P, Vigagni F, Maffei F, Morotti M, Colacci A, Perocco P, Grilli S, Cantelli-Forti G. Genetic safety evaluation of pesticides in different short-term tests. Mutation Research. 321: 219-28. PMID 7515160 DOI: 10.1016/0165-1218(94)90073-6  0.552
1993 Hrelia P, Vigagni F, Morotti M, Forti GC, Barbieri CL, Spinelli D, Lamartina L. Mechanism of genotoxicity and electron density distribution by NMR of 5-nitro-3-thiophenecarboxamides, a novel group of direct-acting mutagens in Salmonella typhimurium. Chemico-Biological Interactions. 86: 229-54. PMID 8485786 DOI: 10.1016/0009-2797(93)90100-d  0.558
1993 Hrelia P, Morotti M, Vigagni F, Burnelli S, Garuti L, Sabatino P, Cantelli-forti G. Synthesis of a series of 5-nitro-(benzimidazoles and indoles) as novel antimycotics and evaluation as genotoxins in the ames test Mutagenesis. 8: 183-188. PMID 8332079 DOI: 10.1093/mutage/8.3.183  0.563
1993 Hrelia P, Morotti M, Vigagni F, Maffei F, Paolini M, Forti GC. Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. Basic Life Sciences. 61: 325-34. PMID 8304945  0.563
1991 Paolini M, Sapigni E, Hrelia P, Scotti M, Morotti M, Cantelli-Forti G. Wide spectrum detection of precarcinogens in short-term bioassays by simultaneous superinduction of multiple forms of cytochrome P450 isoenzymes. Carcinogenesis. 12: 759-66. PMID 1903089  0.562
1990 Hrelia P, Morotti M, Scotti M, Vigagni F, Paolini M, Perocco P, Cantelli Forti G. Genotoxic risk associated with pesticides: evidences on short-term tests. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 22: 93-4. PMID 2097665  0.534
1990 Hrelia P, Scotti M, Morotti M, Vigagni F, Paolini M, Sapigni E, Cantelli-Forti G. Dimethylsulfoxide as modifier of the organospecific mutagenicity of metronidazole in mice. Teratogenesis, Carcinogenesis, and Mutagenesis. 10: 263-71. PMID 1975130  0.551
Show low-probability matches.